Interleukin-12 as an adjuvant for induction of protective antibody responses
- PMID: 20650650
- PMCID: PMC2935143
- DOI: 10.1016/j.cyto.2010.06.011
Interleukin-12 as an adjuvant for induction of protective antibody responses
Abstract
Interleukin (IL)-12 is a pivotal cytokine that strongly stimulates Th1-associated cellular immunity. It is now recognized that IL-12 also activates humoral immunity to both T-dependent and T-independent antigens. This has let to considerable interest in exploiting IL-12 as a vaccine adjuvant for protection against various bacterial and viral pathogens, particularly in the lung. Studies examining the efficacy of IL-12-mediated effects on protective antibody response in the mouse model are summarized in this review.
Copyright 2010 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.Vaccine. 2014 Sep 3;32(39):5035-40. doi: 10.1016/j.vaccine.2014.07.015. Epub 2014 Jul 18. Vaccine. 2014. PMID: 25045812
-
Correlates of vaccine adjuvanticity, vaccine activity, protective immunity and disease in human infectious disease and cancer.Semin Immunol. 2018 Oct;39:1-3. doi: 10.1016/j.smim.2018.10.002. Epub 2018 Oct 11. Semin Immunol. 2018. PMID: 30318307 No abstract available.
-
CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge.J Immunol. 1998 Nov 1;161(9):4563-71. J Immunol. 1998. PMID: 9794383 Free PMC article.
-
Immunizations in the elderly: do they live up to their promise?Wien Med Wochenschr. 2006 Mar;156(5-6):130-41. doi: 10.1007/s10354-006-0267-8. Wien Med Wochenschr. 2006. PMID: 16823527 Free PMC article. Review.
-
IL-12 as an adjuvant for cell-mediated immunity.Semin Immunol. 1997 Oct;9(5):285-91. doi: 10.1006/smim.1997.0084. Semin Immunol. 1997. PMID: 9327523 Review.
Cited by
-
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections.Pharmaceuticals (Basel). 2023 Feb 22;16(3):334. doi: 10.3390/ph16030334. Pharmaceuticals (Basel). 2023. PMID: 36986434 Free PMC article. Review.
-
STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation.Nano Res. 2022;15(7):6328-6339. doi: 10.1007/s12274-022-4282-x. Epub 2022 Apr 18. Nano Res. 2022. PMID: 35464625 Free PMC article.
-
Vaccine Candidates for the Control and Prevention of the Sexually Transmitted Disease Gonorrhea.Vaccines (Basel). 2021 Jul 20;9(7):804. doi: 10.3390/vaccines9070804. Vaccines (Basel). 2021. PMID: 34358218 Free PMC article. Review.
-
Intranasal administration of an inactivated Yersinia pestis vaccine with interleukin-12 generates protective immunity against pneumonic plague.Clin Vaccine Immunol. 2011 Nov;18(11):1925-35. doi: 10.1128/CVI.05117-11. Epub 2011 Aug 31. Clin Vaccine Immunol. 2011. PMID: 21880856 Free PMC article.
-
Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation.Arch Virol. 2020 Sep;165(9):1959-1968. doi: 10.1007/s00705-020-04669-5. Epub 2020 Jun 9. Arch Virol. 2020. PMID: 32519007 Free PMC article.
References
-
- Pabst R. Is BALT a major component of the human lung immune system? Immunol Today. 1992;13:119–122. - PubMed
-
- Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology. 2000;68:1–8. - PubMed
-
- Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med. 2004;10:927–934. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources